Sign Out
Ezetimibe co-administered with a statin is contraindicated during pregnancy and lactation (see Contraindications), refer to the SPC for that particular statin.
Pregnancy: Ezetimibe should be given to pregnant women only if clearly necessary. No clinical data are available on the use of Ezetimibe during pregnancy. Animal studies on the use of Ezetimibe in monotherapy have shown no evidence of direct or indirect harmful effects on pregnancy, embryofoetal development, birth or postnatal development (see Pharmacology: Toxicology: Preclinical safety data under Actions).
Lactation: Ezetimibe should not be used during lactation. Studies on rats have shown that Ezetimibe is secreted into breast milk. It is not known if Ezetimibe is secreted into human breast milk.
Fertility: No clinical trial data are available on the effects of Ezetimibe on human fertility. Ezetimibe had no effect on the fertility of male or female rats (see Pharmacology: Toxicology: Preclinical safety data under Actions).
Continue with Google